{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:11:37Z","timestamp":1788948697101,"version":"build-2803163510"},"reference-count":101,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Skin and soft tissue infections (SSTIs) remain a major clinical challenge due to the increasing prevalence of antimicrobial resistance and biofilm-associated pathogens. Conventional antibiotics are often limited by reduced efficacy, recurrent infections, and disruption of the resident skin microbiota. Consequently, bacteriocins have emerged as promising alternative or adjunctive antimicrobial agents for the treatment of skin and wound infections. Methods: A literature review was conducted using the PubMed, Scopus, and Web of Science databases. Experimental in vitro, ex vivo, and in vivo studies investigating bacteriocins in skin and wound infection models were analyzed, with a focus on antimicrobial activity, antibiofilm efficacy, activity against antimicrobial-resistant pathogens, and formulation strategies designed to improve therapeutic performance. Results: Available evidence demonstrates that numerous bacteriocins exhibit potent antimicrobial activity against clinically relevant skin-associated pathogens, particularly Staphylococcus aureus, including methicillin-resistant strains (MRSA). Several bacteriocins also showed significant antibiofilm properties and synergistic interactions with conventional antibiotics, resulting in enhanced bacterial eradication and reduced risk of resistance development. Experimental infection models further support their therapeutic potential in wound-associated infections. Additionally, advanced delivery platforms, including hydrogels, wound dressings, nanofibers, and lipid-based nanoparticles, improved peptide stability, sustained release, and local antimicrobial efficacy. Conclusions: Bacteriocins are promising candidates for the prevention and treatment of skin and wound infections due to their antimicrobial and antibiofilm activity, low propensity for resistance development, and suitability for topical administration. However, further studies addressing formulation optimization, safety, pharmacokinetics, and clinical validation are required before bacteriocin-based therapies can enter routine clinical practice.<\/jats:p>","DOI":"10.3390\/antibiotics15090884","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:24:02Z","timestamp":1788945842000},"page":"884","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bacteriocins as Alternative Antimicrobial Agents for Wound-Associated Infections: Mechanisms, Activity Against Biofilms and Translational Potential"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1986-2220","authenticated-orcid":false,"given":"Magdalena","family":"Szemraj","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Faculty of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-4176","authenticated-orcid":false,"given":"Monika","family":"Sienkiewicz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Faculty of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41579-024-01035-z","article-title":"The wound microbiota: Microbial mechanisms of impaired wound healing and infection","volume":"22","author":"Uberoi","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cid\/ciz004","article-title":"Current Treatment Options for Acute Skin and Skin-Structure Infections","volume":"68","author":"Golan","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Shen, A.Z., Taha, M., Ghannoum, M., and Tyring, S.K. (2025). Biofilms and Chronic Wounds: Pathogenesis and Treatment Options. J. Clin. Med., 14.","DOI":"10.3390\/jcm14217784"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/QCO.0000000000000239","article-title":"Epidemiology and microbiology of skin and soft tissue infections","volume":"29","author":"Esposito","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cavallo, I., Sivori, F., Mastrofrancesco, A., Abril, E., Pontone, M., Di Domenico, E.G., and Pimpinelli, F. (2024). Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches. Biology, 13.","DOI":"10.3390\/biology13020109"},{"key":"ref_7","unstructured":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins\u2014A viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00253-016-7343-9","article-title":"Bacteriocins of lactic acid bacteria: Extending the family","volume":"100","author":"Mu","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.08.016","article-title":"Antimicrobial potential of bacteriocins: In therapy, agriculture and food preservation","volume":"49","author":"Ahmad","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"fuaa039","DOI":"10.1093\/femsre\/fuaa039","article-title":"Bacteriocins as a new generation of antimicrobials: Toxicity aspects and regulations","volume":"45","author":"Soltani","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijbiomac.2021.11.136","article-title":"Antibacterial effect of bacteriocin XJS01 and its application as antibiofilm agents to treat multidrug-resistant Staphylococcus aureus infection","volume":"196","author":"Xiang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Karau, M.J., Koscianski, C.A., Badley, A.D., Bedard, N.A., Zinckgraf, J.W., and Patel, R. (2025). In Vitro Activity of Nisin A Against Staphylococci Isolated from Periprosthetic Joint Infection. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050515"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s40001-022-00804-x","article-title":"The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"27","author":"Ghapanvari","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00248-024-02357-4","article-title":"Revisiting the Multifaceted Roles of Bacteriocins","volume":"87","author":"Arbulu","year":"2024","journal-title":"Microb. Ecol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Solis-Balandra, M.A., and Sanchez-Salas, J.L. (2024). Classification and Multi-Functional Use of Bacteriocins in Health, Biotechnology, and Food Industry. Antibiotics, 13.","DOI":"10.3390\/antibiotics13070666"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yang, S.-C., Lin, C.-H., Sung, C.T., and Fang, J.-Y. (2014). Antibacterial activities of bacteriocins: Application in foods and pharmaceuticals. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00241"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/femsre\/fuw034","article-title":"Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials","volume":"41","author":"Kuipers","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zimina, M., Babich, O., Prosekov, A., Sukhikh, S., Ivanova, S., Shevchenko, M., and Noskova, S. (2020). Overview of global trends in classification, methods of preparation and application of bacteriocins. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090553"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2147\/IDR.S215070","article-title":"Therapeutic compounds targeting Lipid II for antibacterial purposes","volume":"12","author":"Malin","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e02050-19","DOI":"10.1128\/AAC.02050-19","article-title":"An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium","volume":"64","author":"Zhao","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","first-page":"1387","article-title":"Structural features, mechanisms of action, and prospects for practical application of Class II bacteriocins","volume":"87","author":"Antoshina","year":"2022","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e3733","DOI":"10.15414\/jmbfs.3733","article-title":"Classification and mechanism of bacteriocin induced cell death: A review","volume":"11","author":"Sharma","year":"2021","journal-title":"J. Microbiol. Biotechnol. Food Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1128\/AEM.02602-10","article-title":"Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system","volume":"77","author":"Kjos","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41579-024-01045-x","article-title":"Bacteriocin diversity, function, discovery and application as antimicrobials","volume":"22","author":"Sugrue","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-virology-101416-041632","article-title":"Phage tail\u2013like bacteriocins","volume":"4","author":"Scholl","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12275-023-00023-x","article-title":"The \u201cCins\u201d of Our Fathers: Rejuvenated Interest in Colicins to Combat Drug Resistance","volume":"61","author":"Upatissa","year":"2023","journal-title":"J. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/MMBR.00036-06","article-title":"Colicin biology","volume":"71","author":"Cascales","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Simons, A., Alhanout, K., and Duval, R.E. (2020). Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of Their Biology and Their Impact against Multidrug-Resistant Bacteria. Microorganisms, 8.","DOI":"10.3390\/microorganisms8050639"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Baquero, F., Lanza, V.F., Baquero, M.-R., Del Campo, R., and Bravo-V\u00e1zquez, D.A. (2019). Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02261"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s44259-025-00088-1","article-title":"R-pyocins as targeted antimicrobials against Pseudomonas aeruginosa","volume":"3","author":"Mei","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"a018218","DOI":"10.1101\/cshperspect.a018218","article-title":"Epidermal Barriers","volume":"4","author":"Natsuga","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.tim.2023.01.009","article-title":"The epidermal lipid barrier in microbiome-skin interaction","volume":"31","author":"Tchoupa","year":"2023","journal-title":"Trends Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2361197","DOI":"10.1080\/21688370.2024.2361197","article-title":"The stratum corneum barrier: Impaired function in relation to associated lipids and proteins","volume":"13","author":"Chen","year":"2025","journal-title":"Tissue Barriers"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrmicro2537","article-title":"The skin microbiome","volume":"9","author":"Grice","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri3228","article-title":"Epithelial antimicrobial defence of the skin and intestine","volume":"12","author":"Gallo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/jid.2011.387","article-title":"Antimicrobial peptides: Old molecules with new ideas","volume":"132","author":"Nakatsuji","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41385-022-00505-y","article-title":"Skin immunity: Dissecting the complex biology of our body\u2019s outer barrier","volume":"15","author":"Zhang","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"112494","DOI":"10.1016\/j.celrep.2023.112494","article-title":"Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. Aureus","volume":"42","author":"Nakatsuji","year":"2023","journal-title":"Cell Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eaah4680","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, M., Paw\u0142owska, A., Orze\u0142, A., Sulej, L., Muzyka-Placzy\u0144ska, K., Baran, A., Filipecka-Tyczka, D., Paw\u0142owska, P., Nowi\u0144ska, A., and Bogus\u0142awska, J. (2023). Wound Microbiota and Its Impact on Wound Healing. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417318"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: A review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/QCO.0000000000000800","article-title":"New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections","volume":"35","author":"Hindy","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/QCO.0000000000000989","article-title":"Current challenges in acute bacterial skin infection management","volume":"37","author":"Burillo","year":"2024","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Linz, M.S., Mattappallil, A., Finkel, D., and Parker, D. (2023). Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030557"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Touaitia, R., Mairi, A., Ibrahim, N.A., Basher, N.S., Idres, T., and Touati, A. (2025). Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050470"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100175","DOI":"10.1016\/j.bioflm.2023.100175","article-title":"Staphylococcus aureus biofilm: Formulation, regulatory, and emerging natural products-derived therapeutics","volume":"7","author":"Wu","year":"2024","journal-title":"Biofilm"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Cho, K.H. (2024). Molecular Targets in Streptococcus pyogenes for the Development of Anti-Virulence Agents. Genes, 15.","DOI":"10.3390\/genes15091166"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"fuaf058","DOI":"10.1093\/femsre\/fuaf058","article-title":"Global spread of Streptococcus pyogenes A genomics-supported narrative review","volume":"49","author":"Arcari","year":"2025","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","article-title":"Pathogenesis, epidemiology and control of Group A Streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10.1128","DOI":"10.1128\/microbiolspec.GPP3-0054-2018","article-title":"Toxins and Superantigens of Group A Streptococci","volume":"7","author":"Shannon","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sanya, D.R.A., On\u00e9sime, D., Vizzarro, G., and Jacquier, N. (2023). Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections. BMC Microbiol., 23.","DOI":"10.1186\/s12866-023-02832-x"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yamberla, I., Pupiales, C., Chiliquinga, A.J., Sulca-Villamar\u00edn, T., Plasencia, A., Cabrera, A.F., D\u00edaz, R.F., Caicedo, A., and Barba, P.M. (2025). Pseudomonas aeruginosa pathogenicity and its interaction with other microorganisms during the skin wound healing process. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199677"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"13627","DOI":"10.1038\/s41598-019-50003-8","article-title":"Formation of Pseudomonas aeruginosa biofilms in full-thickness scald burn wounds in rats","volume":"9","author":"Brandenburg","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Tuon, F.F., Dantas, L.R., Suss, P.H., and Ribeiro, V.S.T. (2022). Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review. Pathogens, 11.","DOI":"10.3390\/pathogens11030300"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Lee, C.-R., Lee, J.H., Park, M., Park, K.S., Bae, I.K., Kim, Y.B., Cha, C.-J., Jeong, B.C., and Lee, S.H. (2017). Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2017.00055"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Szemraj, M., Piechota, M., Olszowiec, K., Wicha, J., Pruss, A., Sienkiewicz, M., Witeska, M., Szweda, P., and Kot, B. (2025). High prevalence of virulence and blaoxa genes encoding carbapenemases among Acinetobacter baumannii isolates from hospitalised patients in three regions of Poland. Pathogens, 14.","DOI":"10.3390\/pathogens14080731"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2147\/IDR.S332051","article-title":"Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review","volume":"10","author":"Gedefie","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.chom.2019.03.006","article-title":"Strain and species level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy","volume":"25","author":"Kalan","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","article-title":"The prevalence of biofilms in chronic wounds: A systematic review and meta-analysis of published data","volume":"26","author":"Malone","year":"2017","journal-title":"J. Wound Care"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Buj\u0148\u00e1kov\u00e1, D., Puva\u010da, N., and \u0106irkovi\u0107, I. (2022). Virulence factors and antibiotic resistance of Enterobacterales. Microorganisms, 10.","DOI":"10.3390\/microorganisms10081588"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"107243","DOI":"10.1016\/j.ijantimicag.2024.107243","article-title":"Strategies for controlling polymicrobial biofilms: A focus on antibiofilm agents","volume":"64","author":"Jeong","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/all.15640","article-title":"Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction","volume":"78","author":"Kim","year":"2023","journal-title":"Allergy"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Lesiak, A., Paprocka, P., Wnorowska, U., Ma\u0144kowska, A., Kr\u00f3l, G., G\u0142uszek, K., Piktel, E., Spa\u0142ek, J., Ok\u0142a, S., and Fiedoruk, K. (2024). Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris. Front. Immunol., 18.","DOI":"10.3389\/fimmu.2024.1502242"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000335598","article-title":"In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains","volume":"57","author":"Dosler","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Charest, A.M., Reed, E., Bozorgzadeh, S., Hernandez, L., Getsey, N.V., Smith, L., Galperina, A., Beauregard, H.E., Charest, H.A., and Mitchell, M. (2024). Nisin Inhibition of Gram-Negative Bacteria. Microorganisms, 12.","DOI":"10.3390\/microorganisms12061230"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Vel\u00e1zquez-Su\u00e1rez, C., Cebri\u00e1n, R., Gasca-Capote, C., Sorl\u00f3zano-Puerto, A., Guti\u00e9rrez-Fern\u00e1ndez, J., Mart\u00ednez-Bueno, M., Maqueda, M., and Valdivia, E. (2021). Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant Staphylococcus aureus. Antibiotics, 10.","DOI":"10.3390\/antibiotics10080925"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lynch, D., O\u2019Connor, P.M., Cotter, P.D., Hill, C., Field, D., and Begley, M. (2019). Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223541"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jac\/dkp221","article-title":"A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species","volume":"64","author":"Piper","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Song, Y., Zhou, Y., and Pan, Y. (2024). Discovery and Characterization of a Novel Bacteriocin That Strongly Inhibits Staphylococcus aureus. Fermentation, 10.","DOI":"10.3390\/fermentation10070355"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"109539","DOI":"10.1016\/j.ijfoodmicro.2022.109539","article-title":"The antibacterial activity of plantaricin GZ1-27 against MRSA and its bio-preservative effect on chilled pork in combination with chitosan","volume":"365","author":"Du","year":"2022","journal-title":"Int. J. Food Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00203-014-0958-2","article-title":"Purification and characterization of plantaricin Y, a novel bacteriocin produced by Lactobacillus plantarum 510","volume":"196","author":"Chen","year":"2014","journal-title":"Arch. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jiph.2021.09.029","article-title":"Bacteriocin producing microbes with bactericidal activity against multidrug resistant pathogens","volume":"14","author":"Leslie","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/AAC.05397-11","article-title":"Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci","volume":"56","author":"Sandiford","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e00606","DOI":"10.1002\/mbo3.606","article-title":"The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes bacteria-induced proinflammatory responses in dermal fibroblasts","volume":"7","author":"Bengtsson","year":"2018","journal-title":"Microbiol. Open"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"106610","DOI":"10.1016\/j.pep.2024.106610","article-title":"Anti-biofilm and antibacterial effect of bacteriocin derived from Lactobacillus plantarum on the multidrug-resistant Acinetobacter baumannii","volume":"226","author":"Javadi","year":"2025","journal-title":"Protein Expr. Purif."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.1021\/acs.jafc.3c04617","article-title":"Discovery and Characterization of a Novel Bacteriocin HA2-5 that Strongly Inhibits Propionibacterium acnes","volume":"71","author":"Peng","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Qiao, X., Sun, X., Wang, S., Zhai, C., Tang, W., Tang, T., Zhang, J., and He, Z. (2025). Characterization of Flexusin A, a Novel Circular Bacteriocin Produced by Marine Bacterium Bacillus flexus R29-2. Mar. Drugs, 23.","DOI":"10.3390\/md23030095"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/1751-7915.14096","article-title":"Antibacterial activity and cytotoxicity of a novel bacteriocin isolated from Pseudomonas sp. strain 166","volume":"15","author":"Wang","year":"2022","journal-title":"Microb. Biotechnol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ijbiomac.2020.10.126","article-title":"Identification and characterization of Pseudomonas aeruginosa derived bacteriocin for industrial applications","volume":"165","author":"Lakshmanan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41392-024-01866-5","article-title":"Bacterial persisters: Molecular mechanisms and therapeutic development","volume":"9","author":"Niu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2415598","DOI":"10.1080\/19420889.2024.2415598","article-title":"Quorum sensing and antibiotic resistance in polymicrobial infections","volume":"17","author":"Cui","year":"2024","journal-title":"Commun. Integr. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Wang, J., Mal, X., Li, J., Shi, L., Liu, L., Hou, X., Jiang, S., Li, P., Lv, J., and Han, L. (2023). The Synergistic Antimicrobial Effect and Mechanism of Nisin and Oxacillin against Methicillin-Resistant Staphylococcus aureus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076697"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Ovchinnikov, K.V., Kranjec, C., Telke, A., Kjos, M., Thorstensen, T., Scherer, S., Carlsen, H., and Diep, D. (2021). A strong synergy between the thiopeptide bacteriocin micrococcin P1 and rifampicin against MRSA in a murine skin infection model. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.676534"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e00829-20","DOI":"10.1128\/AAC.00829-20","article-title":"Successful development of bacteriocins into therapeutic formulation for treatment of MRSA skin infection in a murine model","volume":"64","author":"Ovchinnikov","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/wrr.12743","article-title":"Immunomodulatory potential of Nisin A with application in wound healing","volume":"27","author":"Mouritzen","year":"2019","journal-title":"Wound Repair Regen."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.00622-13","article-title":"Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice","volume":"57","author":"Heunis","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mahlapuu, M., H\u00e5kansson, J., Ringstad, L., and Bj\u00f6rn, C. (2016). Antimicrobial peptides: An emerging category of therapeutic agents. Front. Cell. Infect. Microbiol., 6.","DOI":"10.3389\/fcimb.2016.00194"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"105333","DOI":"10.1016\/j.ejps.2020.105333","article-title":"Preformulation studies on novel garvicin KS peptides for topical applications","volume":"1","author":"Thapa","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"47226","DOI":"10.1021\/acsami.4c09309","article-title":"Hyaluronic Acid\/Gelatin-Based Multifunctional Bioadhesive Hydrogel Loaded with a Broad-Spectrum Bacteriocin for Enhancing Diabetic Wound Healing","volume":"16","author":"Yin","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s13346-023-01332-9","article-title":"The development of a solid lipid nanoparticle (SLN)-based lacticin 3147 hydrogel for the treatment of wound infections","volume":"13","author":"Ryan","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Baral, B. (2023). Phages against killer superbugs: An enticing strategy against antibiot-ics-resistant pathogens. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1036051"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-virology-012423-110530","article-title":"Developing Phage Therapy That Overcomes the Evolution of Bacterial Resistance","volume":"10","author":"Antani","year":"2023","journal-title":"Annu. Rev. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/D2BM01276F","article-title":"Inhibition and eradication of bacterial biofilm using polymeric materials","volume":"11","author":"Banerjee","year":"2022","journal-title":"Biomater. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2402588","DOI":"10.1002\/adfm.202402588","article-title":"Nanomaterials in An-tibacterial Photodynamic Therapy and Antibacterial Sonodynamic Therapy","volume":"34","author":"He","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e2401211","DOI":"10.1002\/adhm.202401211","article-title":"Advancements of Porphyrin-Derived Nano-materials for Antibacterial Photodynamic Therapy and Biofilm Eradication","volume":"13","author":"Chen","year":"2024","journal-title":"Rev. Adv. Healthc. Mater."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wayah, S.B., Arakawa, K., and Philip, K. (2026). Bacteriocins from Limosilactobacillus and Ligilactobacillus: Ecological logic, mechanistic diversity, and translational potential in the post- Lactobacillus taxonomy. Front. Microbiol., 17.","DOI":"10.3389\/fmicb.2026.1875597"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/9\/884\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:03:35Z","timestamp":1788948215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/9\/884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":101,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["antibiotics15090884"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15090884","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}